Chemed Future Growth
Future criteria checks 2/6
Chemed is forecast to grow earnings and revenue by 13.2% and 6.8% per annum respectively while EPS is expected to grow by 12.8% per annum.
Key information
13.2%
Earnings growth rate
12.8%
EPS growth rate
Healthcare earnings growth | 23.4% |
Revenue growth rate | 6.8% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 02 May 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 2,763 | N/A | N/A | N/A | 1 |
12/31/2025 | 2,602 | 357 | N/A | N/A | 3 |
12/31/2024 | 2,436 | 317 | N/A | N/A | 3 |
3/31/2024 | 2,293 | 283 | 302 | 354 | N/A |
12/31/2023 | 2,264 | 273 | 273 | 330 | N/A |
9/30/2023 | 2,225 | 245 | 259 | 322 | N/A |
6/30/2023 | 2,187 | 226 | 280 | 345 | N/A |
3/31/2023 | 2,165 | 240 | 208 | 269 | N/A |
12/31/2022 | 2,135 | 250 | 253 | 310 | N/A |
9/30/2022 | 2,129 | 262 | 220 | 273 | N/A |
6/30/2022 | 2,141 | 277 | 284 | 334 | N/A |
3/31/2022 | 2,142 | 267 | 249 | 303 | N/A |
12/31/2021 | 2,139 | 269 | 250 | 309 | N/A |
9/30/2021 | 2,132 | 308 | 271 | 332 | N/A |
6/30/2021 | 2,121 | 303 | 283 | 344 | N/A |
3/31/2021 | 2,091 | 329 | 450 | 507 | N/A |
12/31/2020 | 2,080 | 319 | 430 | 489 | N/A |
9/30/2020 | 2,069 | 271 | 410 | 466 | N/A |
6/30/2020 | 2,021 | 263 | 413 | 470 | N/A |
3/31/2020 | 1,992 | 231 | 258 | 317 | N/A |
12/31/2019 | 1,939 | 220 | 248 | 301 | N/A |
9/30/2019 | 1,874 | 209 | 238 | 294 | N/A |
6/30/2019 | 1,837 | 201 | 218 | 275 | N/A |
3/31/2019 | 1,806 | 205 | 241 | 296 | N/A |
12/31/2018 | 1,783 | 206 | 234 | 287 | N/A |
9/30/2018 | 1,753 | 206 | 152 | 202 | N/A |
6/30/2018 | 1,727 | 190 | 123 | 183 | N/A |
3/31/2018 | 1,700 | 113 | 91 | 159 | N/A |
12/31/2017 | 1,667 | 98 | N/A | 162 | N/A |
9/30/2017 | 1,642 | 76 | N/A | 198 | N/A |
6/30/2017 | 1,617 | 67 | N/A | 162 | N/A |
3/31/2017 | 1,592 | 114 | N/A | 197 | N/A |
12/31/2016 | 1,577 | 109 | N/A | 135 | N/A |
9/30/2016 | 1,572 | 106 | N/A | 187 | N/A |
6/30/2016 | 1,566 | 108 | N/A | 175 | N/A |
3/31/2016 | 1,557 | 111 | N/A | 166 | N/A |
12/31/2015 | 1,543 | 110 | N/A | 172 | N/A |
9/30/2015 | 1,524 | 110 | N/A | 172 | N/A |
6/30/2015 | 1,496 | 106 | N/A | 135 | N/A |
3/31/2015 | 1,475 | 103 | N/A | 134 | N/A |
12/31/2014 | 1,456 | 99 | N/A | 110 | N/A |
9/30/2014 | 1,425 | 92 | N/A | 66 | N/A |
6/30/2014 | 1,408 | 85 | N/A | 111 | N/A |
3/31/2014 | 1,405 | 76 | N/A | 131 | N/A |
12/31/2013 | 1,413 | 77 | N/A | 151 | N/A |
9/30/2013 | 1,433 | 81 | N/A | 190 | N/A |
6/30/2013 | 1,447 | 84 | N/A | 162 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CXM's forecast earnings growth (13.2% per year) is above the savings rate (0.7%).
Earnings vs Market: CXM's earnings (13.2% per year) are forecast to grow slower than the German market (15.6% per year).
High Growth Earnings: CXM's earnings are forecast to grow, but not significantly.
Revenue vs Market: CXM's revenue (6.8% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: CXM's revenue (6.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CXM's Return on Equity is forecast to be high in 3 years time